TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Investor Investigation Over Possible Violations of Securities Laws Announced

  • If you purchased shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Infinity Pharmaceuticals Inc.
Security
NASDAQ: INFI

Summary

May 20, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) shares over potential securities laws violations by Infinity Pharmaceuticals Inc. and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) concerning whether a series of statements by Infinity Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) grew from $22.525 in early Dec. 2012 to as high as over $50 per share in early April 2013.

Then on May 7, 2013, Infinity Pharmaceuticals Inc. reported its Frist Quarter 2013 Financial Results.

Shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) declined to as low as $23.38 per share on May 17, 2013.

On May 20, 2013, shares of Infinity Pharmaceuticals Inc closed at $25.61 per share.

Start Monitoring Your Investments